Xiuli Yang

机构：Chengdu University of Traditional Chinese Medicine · ORCID：0000-0001-6111-9927

发表论文 22 篇 · 总被引 112 次 · h-index 6

代表论文

• Comparison of diagnostic performance of AFP, DCP and two diagnostic models in hepatocellular carcinoma: a retrospective study (2023 · Annals of Hepatology · 被引 19)
• Inetetamab for injection in combination with vinorelbine weekly or every three weeks in HER2-positive metastatic breast cancer: A multicenter, randomized, phase II clinical trial (2024 · Journal of Translational Internal Medicine · 被引 18)
• A phase 1/2 study of LM-302, an anti-claudin 18.2 (CLDN18.2) antibody-drug conjugate in patients with advanced gastric/gastroesophageal junction cancer. (2024 · Journal of Clinical Oncology · 被引 15)
• Tecotabart vedotin in Claudin 18.2-positive advanced gastric/gastroesophageal junction cancer: A Bayesian phase 1/2 clinical trial (2025 · European Journal of Cancer · 被引 11)
• Efficacy and safety of LM-108, an anti-CCR8 monoclonal antibody, in combination with an anti-PD-1 antibody in patients with gastric cancer: Results from phase 1/2 studies. (2024 · Journal of Clinical Oncology · 被引 10)
• Curcumin mediates oxidative stress to play an anti-fibrotic role, focusing on liver, renal, myocardial and pulmonary fibrosis (2025 · Frontiers in Pharmacology · 被引 7)